Management and outcomes of histoplasmosis in youth with inflammatory bowel disease in an endemic area

Ähnliche Einträge

• Proactive therapeutic drug monitoring and vedolizumab dose optimization in children with inflammatory bowel disease
  von: Patrick Rowland, et al.
  Veröffentlicht: (2024)
• Relationships of race and area deprivation indices to outcomes in pediatric patients with inflammatory bowel disease
  von: Faria Hasan, et al.
  Veröffentlicht: (2024)
• Hyperamylasaemia in paediatric inflammatory bowel disease: Aetiology, outcomes and genetic determinants
  von: Fernando Vázquez López, et al.
  Veröffentlicht: (2026)
• Role of ileal diversion in pediatric inflammatory bowel disease
  von: Amanda A. Simard, et al.
  Veröffentlicht: (2024)
• Upadacitinib is associated with clinical response and steroid‐free remission for children and adolescents with inflammatory bowel disease
  von: Joseph Runde, et al.
  Veröffentlicht: (2024)